PRO VITALITY - TRE-EN-EN GRAIN CONCENTRATES
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Saumon Potency : 160 mg Decosahexaenoic acid | 690 mg | Not calculated |
| Huile de poisson Source : Saumon Potency : 150 mg Eicosapenaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Saumon Potency : 15 mg DEcosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Sardine Potency : 160 mg Decosahexaenoic acid | 690 mg | Not calculated |
| Huile de poisson Source : Sardine Potency : 150 mg Eicosapenaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Sardine Potency : 15 mg DEcosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Thon Potency : 160 mg Decosahexaenoic acid | 690 mg | Not calculated |
| Huile de poisson Source : Thon Potency : 150 mg Eicosapenaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Thon Potency : 15 mg DEcosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Corps entier Potency : 160 mg Decosahexaenoic acid | 690 mg | Not calculated |
| Huile de poisson Source : Corps entier Potency : 150 mg Eicosapenaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Corps entier Potency : 15 mg DEcosapentaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Anchois Potency : 160 mg Decosahexaenoic acid | 690 mg | Not calculated |
| Huile de poisson Source : Anchois Potency : 150 mg Eicosapenaenoic acid | Not specified | Not calculated |
| Huile de poisson Source : Anchois Potency : 15 mg DEcosapentaenoic acid | Not specified | Not calculated |
| Spinacia oleracea | 24 mg | Not calculated |
| Triticum aestivum Source : Kernel Potency : 50 % Linoleic acid | 150 mg | Not calculated |
| Vitamine E | 4 mg AT | Not calculated |
| Capsicum annuum | 39.89 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, gélatine de bovin, huile d'olive, Dioxyde de silicium, Glycérine, chlorophylline de cuivre sodium, Pêche, Dioxyde de titane, Abricot, Cire d'abeille jaune, Amidon de maïs, Lécithine, Annatto extract, mélange de tocophérols, Strawberry
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 12 years | 3 packet | Not specified |
| Adultes | Not specified | 3 packet | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of essential fatty acids to support good health. Source of provitamin A to help maintain eyesight, skin, membranes and immune function. Vitamin E as an antioxidant for the maintenance of good health. Omega III fatty acids, in particular DHA, are important for the visual and neuronal development in children up to 12 years of age. Omega III fatty acids, EPA and DHA, have been shown to support healthy cardiovascular function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Licence holder
- NeoLife Wellness International, Ltd.
- NPN or DIN-HM
- 80028466
- Status
- Active licence
- Licence date
- 5 December 2011
- Revision date
- 29 July 2022
- Form
- Packet
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80028466
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Huile de poisson
Read the warning, when it applies and the studies cited
FISH OIL
Route of administration: Oral
Cautions and warnings
Condition of application: Pain of rheumatoid arthritis.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Condition of application: Healthy mood balance.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.
- Capsicum annuum
Read the warning, when it applies and the studies cited
CAYENNE - CAPSICUM ANNUUM Oral
Cautions and warnings
Condition of application: All products.
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).
Sources cited by Health Canada (2)
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Condition of application: Digestion; Peripheral circulation.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 27 March 2026
CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical
Cautions and warnings
Condition of application: All products.
For external use only (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).
Sources cited by Health Canada (1)
- US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).
Sources cited by Health Canada (1)
- CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.
Known adverse reactions
Condition of application: All products.
Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).
Sources cited by Health Canada (5)
- APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
- Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
- Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
- McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Randomised trial
- Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Systematic review
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “PRO VITALITY - TRE-EN-EN GRAIN CONCENTRATES (NeoLife Wellness International, Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80028466-pro-vitality-tre-en-en-grain-concentrates, updated 29 July 2022.